Lisdexamfetamine Dimesylate Capsule
Alvogen · Available
Open FDA's page for this record- Update type
- Reverified
- Initial posting date
- 07/14/2023
- Package NDC
- 47781-562-01
- Generic name
- Lisdexamfetamine Dimesylate Capsule
- Contact info
- 844-842-8672 and email: CustomerService-US@alvogen.com
- Availability
- Available
- Update date
- 09/17/2026
- Dosage form
- Capsule
- Presentation
- Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 47781-562-01)
- Company name
- Alvogen
- Status
- Current
- Therapeutic category
- Psychiatry
- Harmonized identifiers (openFDA)
- Application number
- ANDA214547
- Brand name
- LISDEXAMFETAMINE DIMESYLATE
- Generic name
- LISDEXAMFETAMINE DIMESYLATE
- Manufacturer name
- Alvogen Inc.
- Product NDC
- 47781-562, 47781-563, 47781-564, 47781-565, 47781-566, 47781-567, 47781-568
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Substance name
- LISDEXAMFETAMINE DIMESYLATE
- RxCUI
- 854830, 854834, 854838, 854842, 854846, 854850, 1593856
- SPL ID
- db02ec6b-f17f-ab22-b671-e1ddb90e017c
- SPL set ID
- 7f2dd6ee-3363-c87c-9693-ed838942556c
- Package NDC
- 47781-562-01, 47781-563-01, 47781-564-01, 47781-565-01, 47781-566-01, 47781-567-01, 47781-568-01
- UNII
- SJT761GEGS